The Board of Scientific Counselors of the National Center for Injury Prevention and Control (BSC/NCIPC) is one of the federal advisory committees of the Centers for Disease Control and Prevention. Board of Scientific Counselors of the National Center for Injury Prevention and Control (BSC/NCIPC).The BSC/NCIPC reviewed the OWG’s report and provided recommendations to the Department of Health and Human Services (HHS), which oversees CDC.An opportunity for public comment was published in the Federal Register: Federal Register :: Board of Scientific Counselors, National Center for Injury Prevention and Control (BSC, NCIPC) The OWG presented its report to the BSC/NCIPC at a public meeting on July 16, 2021.The workgroup reviewed the processes used for community engagement, the framework used to rate the quality of evidence, and the draft of the Guideline update. The OWG was established on December 4, 2019, and held 11 virtual meetings from October 2020 through June 2021.The members represented a diversity of perspectives, backgrounds, experiences, sexes, races/ethnicities, and geographic regions. The OWG also included clinicians and subject matter experts. OWG members included patients with pain, caregivers, and family members of patients with pain. The primary purpose of the OWG was to review the draft updated Guideline (as prepared by CDC) and to deliver a report describing the OWG’s findings and observations about the draft to the BSC/NCIPC. The Opioid Working Group was established to provide independent, broad, external, transparent input on the diverse and complex issues involved in updating the Guideline.
CDC UPDATED GUIDELINES UPDATE
Sources of input used to inform the update of the Guideline include: CDC highly values public engagement and has ensured there are multiple opportunities to hear from and incorporate feedback from patients with pain, caregivers, clinicians, and partners. The update to the Guideline is following a similar process and includes several opportunities for community and partner engagement. The 2016 Guideline was developed using the best available scientific evidence and followed a rigorous scientific process. The update process uses multiple key sources of input.
As a result of these reviews, CDC determined that an update of the Guideline, and an expansion to certain acute conditions, was warranted. CDC has stayed abreast of new research as it became available since 2016 and conducted formal reviews of new available evidence on noninvasive, nonpharmacological treatment and nonopioid pharmacological treatment of chronic pain. In the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain, CDC indicated the intent to re-evaluate the Guideline as new evidence became available and to determine when sufficient new evidence might prompt an update. The 2016 CDC Guideline for Prescribing Opioids is being updated. In this context, our ultimate goal is to help people set and achieve personal goals to reduce pain and improve function. One key way we do promote patient-centered pain care is through the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain.
CDC provides guidance to clinicians, as well as tools and resources for patients and clinicians, to help advance comprehensive pain care. 1Ī key aim of pain management is the provision of individualized, patient-centered care that focuses on optimizing function and supporting activities of daily living. Chronic pain is the leading cause of disability in the United States and the economic costs are staggering-$560 to $635 billion dollars annually. It contributes to substantial morbidity and mortality in the United States each year. Pain, particularly chronic pain, can lead to impaired physical functioning, poor mental health, and a reduced quality of life. Patients with pain deserve safe and effective pain management.
0 kommentar(er)
